Clinical trials of interventional oncology-moving from efficacy to outcomes

Area of Science:

• Oncology
• Interventional Radiology
• Clinical Trials

Background:

• Interventional oncology is a rapidly advancing field developing novel treatments for various cancers.
• Current evidence relies heavily on single-arm studies, limiting widespread clinical practice adoption.
• There's a need for more robust data to support the integration of interventional oncology into standard care.

Purpose of the Study:

• To review the necessity of incorporating cost-effectiveness and patient-reported outcomes into interventional oncology trials.
• To highlight strategies for designing large-scale studies that provide robust evidence for clinical practice change.
• To discuss innovative trial designs and lessons learned from other medical fields.

Main Methods:

• Review of current evidence and trial designs in interventional oncology.
• Discussion of challenges and opportunities for future research.
• Exploration of registry-based models for data collection.

Main Results:

• Single-arm studies, while useful for technique development, are insufficient for uniform clinical practice change.
• Integrating cost-effectiveness and patient-reported outcomes is crucial for demonstrating the value of interventional oncology.
• Innovative trial designs and registry-based models can provide robust evidence.

Conclusions:

• Future interventional oncology trials must include cost-effectiveness and patient-reported outcomes to drive clinical practice change.
• Well-designed, large-scale studies are essential for establishing interventional oncology as a standard of care.
• Registry-based models offer a promising avenue for generating real-world evidence.